Now More Than Ever, We Need to Focus on Clinical Trial Participation : Oncology Times
An abstract is unavailable.
Related Articles
Frontiers | Bone damage and health-related quality of life in Hodgkin lymphoma survivors: closing the gaps
In the recent decades, remarkable successes have been recorded in the treatment of Hodgkin’s lymphoma to the point that today it represents one of the…
Prognostic Implications of Vitamin D in Patients With a Hematologic Malignancy at a Large Health System in Wisconsin
By Daniel Mundt, Marianne Klumph, Kayla Heslin, et al., Published on 05/26/21
High incidence of fractures after R-CHOP-like chemotherapy for aggressive B-cell non-Hodgkin lymphomas
Supportive Care in Cancer – Patients with non-Hodgkin lymphoma (NHL) have a median age of 67, with 70% surviving over 5 years. Chemotherapy for aggressive…
Osteonecrosis of the Jaw in Patients Receiving Zoledronic Acid for Bone Metastases
This cohort study defines the cumulative incidence of osteonecrosis of the jaw at 3 years in patients receiving zoledronic acid for metastatic bone disease from…
High platelet count is associated with low bone mineral density: The MrOS Sweden cohort
Osteoporosis International – In elderly ambulatory men, high platelet and high neutrophil counts are related to low bone mineral density (BMD), after adjustment for relevant…
Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma
Key Points. Cumulative fracture incidence after R-CHOP in older patients (>70 years) is high (11.4% at 18 months).Bone involvement, prephase steroids, or eit
Identification of non-Hodgkin lymphoma patients at risk for treatment-related vertebral density loss and fractures
Osteoporosis International – Information on bone loss in treated non-Hodgkin’s lymphoma patients is limited. In this study, we used CT to analyze bone loss as…
Increased risk of osteoporosis following commonly used first-line treatments for lymphoma: a Danish Nationwide Cohort Study
High-dose prednisolone is used in first-line treatment for lymphoma, but the potential adverse impact on bone health is unclear. Danish patients with diffuse large B-cell…
Low Bone Mineral Density and High Bone Turnover in Patients … : HemaSphere
Lymphoma (NHL). We prospectively evaluated bone remodeling pre- and post-chemotherapy in 61 patients with newly diagnosed NHL. First-line chemotherapy resulted in high bone turnover, which…